Related Experiment Video
Updated: Aug 4, 2026
07:55
The Influence of Liver Resection on Intrahepatic Tumor Growth
Published on: April 9, 2016
Survival after hepatic resection for malignant tumours
1Surgical Services, Massachusetts General Hospital, Boston.
The British Journal of Surgery
|October 1, 1992
Summary
Hepatic resection offers a 5-year survival rate of 17% for malignant disease, with clear margins significantly improving outcomes. Factors like tumor differentiation and alpha-fetoprotein levels impact survival in specific cancers.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Hepatic resection is a critical treatment for primary and metastatic liver malignancies.
- Patient selection is crucial for optimizing outcomes after liver surgery.
- Understanding prognostic factors aids in determining surgical candidacy and expected survival.
Purpose of the Study:
- To identify variables influencing patient selection for hepatic resection.
- To analyze prognostic factors affecting survival after liver resection for malignancy.
Main Methods:
- Retrospective analysis of 194 patients undergoing hepatic resection between 1962 and 1988.
- Evaluation of patient demographics, tumor characteristics, and surgical factors.
- Statistical analysis to determine correlations between variables and 5-year survival rates.
Main Results:
- Overall 5-year survival was 17%; 18% for colorectal metastases.
- Resection margins >5 mm correlated with significantly better survival (27% vs. 9%).
- Curative resection, normal alpha-fetoprotein, and absence of extrahepatic spread improved survival.
Conclusions:
- Resection margin status is a key determinant of survival after hepatic resection.
- Tumor differentiation and specific biomarkers (e.g., alpha-fetoprotein) impact prognosis in certain liver cancers.
- Careful patient selection based on prognostic factors is essential for successful hepatic resection.
